SAM
IONS icon

S.A. Mason’s Ionis Pharmaceuticals IONS Stock Holding History

S.A. Mason’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-775
Closed -$31K – 325
2021
Q2 		$31K Hold
775
– – 0.02% 273
2021
Q1 		$35K Sell
775
-300
-28% -$16.7K 0.03% 262
2020
Q4 		$61K Hold
1,075
– – 0.05% 214
2020
Q3 		$51K Hold
1,075
– – 0.05% 212
2020
Q2 		$63K Sell
1,075
-435
-29% -$24.2K 0.07% 202
2020
Q1 		$71K Hold
1,510
– – 0.09% 179
2019
Q4 		$91K Buy
+1,510
New +$90K 0.09% 187

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

S.A. Mason's IONS Position: Q3 2021 in Review

S.A. Mason sold out of Ionis Pharmaceuticals (IONS) in Q3 2021, closing a stake of 775 shares — an estimated $31K sold.

S.A. Mason first reported a position in IONS in Q4 2019 and held it in 7 quarters. The position peaked at $91K in Q4 2019. 324 funds tracked by Wall St. Rank hold IONS as of Q3 2021.

  • S.A. Mason reported no remaining Ionis Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • S.A. Mason sold 775 Ionis Pharmaceuticals shares in Q3 2021, an estimated $31K.
  • S.A. Mason first reported a position in Ionis Pharmaceuticals in Q4 2019 and held it in 7 quarters.
  • S.A. Mason's Ionis Pharmaceuticals position peaked at $91K in Q4 2019.
  • 324 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2021.

Based on S.A. Mason's 13F filing for Q3 2021, filed 12 Oct 2021.